THE PROSTATE CANCER CLINICAL TRIALS CONSORTIUM

The PCCTC was formed to address critically unmet needs in prostate cancer. Our mission is to design, implement, and complete early-phase process driven clinical trials, translating scientific discoveries to improved standards of care.

Learn More +

The PCCTC is changing how prostate cancer drugs are developed. Our unique infrastructure facilitates project co-development between investigators, clinical research sites and industry partners.

View Our Services

Expertise

Internationally recognized leaders in the field, PCCTC investigators come from the nation’s top academic medical centers where they are actively engaged in world class science through cutting-edge translational prostate cancer research.

Our Participating Clinical Research Sites

Recent News +++

PCCTC Investigators Drs. Rathkopf and McBride Receive Prestigious SU2C Grant

Press Releases by PCCTC October 17, 2019

Award will fund novel trial using immunotherapy combined with radiation and hormone therap...

Learn More

PCCTC Germline Genetics Working Group Publishes Results

Press Releases by PCCTC July 29, 2019

Study published in Clinical Genitourinary Cancer argues multidisciplinary efforts are key ...

Learn More

PCCTC Working Group Publishes Genetic Testing Manuscript

Press Releases by PCCTC April 26, 2019

Investigators from the Prostate Cancer Clinical Trials Consortium (PCCTC) formed the Germl...

Learn More

Phase III DORA Study Now Enrolling Patients with mCRPC

Press Releases by PCCTC April 19, 2019

The phase III DORA study (ClinicalTrials.gov Identifier: NCT03574571) led by PCCTC investi...

Learn More

Blood Test Predicts Resistance To Hormonal Therapy

Press Releases by MedPage Today March 18, 2019

AR-V7 successfully predicted resistance to hormonal therapy in advanced prostate cancer

Learn More

Clinical Implications of Genetics in Prostate Cancer

Press Releases by ASCO Daily News February 18, 2019

PCCTC investigator Dr. Heather Cheng discusses future of cancer care.

Learn More
View More News +

Follow Us

A Phase Ib/II Study of Intermittent Talazoparib Plus Temozolomide in Subjects With Metastatic Castration Resistant… https://t.co/y0gsQPSKLb
Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic Adenocarcinoma (N… https://t.co/HINX1wZHaR
RT @urotoday: #mHSPC @ChrisSweens1 and Mary-Ellen Taplin, MD @DanaFarber discuss their approaches for treating patients with metastatic hor…

Join our team of dedicated clinical research professionals! The Prostate Cancer Clinical Trials Consortium is currently seeking a Quality Manager and Clinical Data Manager to help fulfill our…

2018-23944 Clinical Data Manager, Prostate Cancer Clinical Trials Consortium (PCCTC) | Memorial Sloan Kettering Cancer Center Careers

careers.mskcc.org

Committed to world-class science!

Our services translate scientific discoveries into improved standards of care, ensuring efficient trial selection, reporting, site management, clinical operations and data analyses.